isis 5132
Nucleic acidexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 1998 (NCT00003236)
Timeline
1990s
- Jan 1, 1998
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- isis 5132
- isis 5132
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00003892 | Phase 2 | Feb 1, 1999 | Canadian Cancer Trials Group, University of Toronto |
| NCT00003236 | Phase 2 | May 1, 1998 | Eastern Cooperative Oncology Group, National Cancer Institute (NCI), Northwestern University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Canadian Cancer Trials Group | Academic/Hospital | 1 | 1 | 1 | 1999 |
| Eastern Cooperative Oncology Group | Academic/Hospital | 1 | 1 | 1 | 1998 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 1998 |
| Northwestern University | Academic/Hospital | 1 | 0 | 1 | 1998 |
| University of Toronto | Academic/Hospital | 1 | 0 | 1 | 1999 |
5 organizations
Page 1 / 1